PolyNovo reports FY26 revenue of A$150 million and turns free cash flow positive

AI Market Summary
PolyNovo reported FY26 record revenue of A$150m (+16.1% YoY) and a swing to positive free cash flow (A$10.4m), supported by strong U.S. growth and an 89.6% jump in NovoSorb MTX sales. Completion of a new manufacturing facility improves capacity, while insurance proceeds add near-term cash support. The news is company-specific with limited broader market spillover.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-2.37%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
PolyNovo (ASX: PNV) reported FY26 group revenue of A$150 million, up 16.1% year on year. Free cash flow swung to A$10.4 million from -A$10.1 million, while NovoSorb MTX commercial sales rose 89.6%. The company ended the year with A$35.4 million in cash and cash equivalents and said its new manufacturing facility has been completed.